Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1495

  • The following terms were not found in PubMed: 10.3389, .2018.00057.
  • Showing results for 10.3389/suvs .2018.00057. Your search for 10.3389/fsufs.2018.00057 retrieved no results.
1.

Circular Dichroism and Isothermal Titration Calorimetry to Study the Interaction of α-Synuclein with Membranes.

Rovere M.

Methods Mol Biol. 2019;1948:123-143. doi: 10.1007/978-1-4939-9124-2_11.

PMID:
30771175
2.

Cerebral 18F-FDG metabolism alteration in a neuropathic pain model following brachial plexus avulsion: a PET/CT study in rats.

Shen J, Huo BB, Hua XY, Zheng MX, Lu YC, Wu JJ, Shan CL, Xu JG.

Brain Res. 2019 Feb 6. pii: S0006-8993(19)30073-3. doi: 10.1016/j.brainres.2019.02.005. [Epub ahead of print]

PMID:
30738025
3.

FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab.

Scarpelli M, Zahm C, Perlman S, McNeel DG, Jeraj R, Liu G.

J Immunother Cancer. 2019 Jan 30;7(1):23. doi: 10.1186/s40425-019-0516-1.

4.

Comparison of standardized uptake values between 99mTc-HDP SPECT/CT and 18F-NaF PET/CT in bone metastases of breast and prostate cancer.

Arvola S, Jambor I, Kuisma A, Kemppainen J, Kajander S, Seppänen M, Noponen T.

EJNMMI Res. 2019 Jan 24;9(1):6. doi: 10.1186/s13550-019-0475-z.

6.

Status of Membrane Asymmetry in Erythrocytes: Role of Spectrin.

Sarkar S, Bose D, Giri RP, Mukhopadhyay MK, Chakrabarti A.

Adv Exp Med Biol. 2018;1112:3-11. doi: 10.1007/978-981-13-3065-0_1.

PMID:
30637686
7.

Value of CT iterative metal artifact reduction in PET/CT-clinical evaluation in 100 patients.

Reinert CP, la Fougère C, Nikolaou K, Pfannenberg C, Gatidis S.

Br J Radiol. 2019 Jan 14:20180756. doi: 10.1259/bjr.20180756. [Epub ahead of print]

PMID:
30618270
8.

Potential usefulness of 68Ga-citrate PET/CT in detecting infected lower limb prostheses.

Tseng JR, Chang YH, Yang LY, Wu CT, Chen SY, Wan CH, Hsiao IT, Yen TC.

EJNMMI Res. 2019 Jan 3;9(1):2. doi: 10.1186/s13550-018-0468-3.

9.

Uptake in non-affected bone tissue does not differ between [18F]-DCFPyL and [68Ga]-HBED-CC PSMA PET/CT.

Hammes J, Hohberg M, Täger P, Wild M, Zlatopolskiy B, Krapf P, Neumaier B, Schomäcker K, Kobe C, Schmidt M, Dietlein M, Drzezga A.

PLoS One. 2018 Dec 20;13(12):e0209613. doi: 10.1371/journal.pone.0209613. eCollection 2018.

10.

New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.

Schiano C, Soricelli A, De Nigris F, Napoli C.

Expert Rev Clin Immunol. 2019 Mar;15(3):289-301. doi: 10.1080/1744666X.2019.1561283. Epub 2019 Jan 2.

PMID:
30570412
11.

Point Spread Function Reconstruction for Integrated 18F-FET PET/MRI in Patients With Glioma: Does It Affect SUVs and Respective Tumor-to-Background Ratios?

Rogasch JMM, Albers J, Steinkrüger FL, Lukas M, Wedel F, Amthauer H, Furth C.

Clin Nucl Med. 2018 Dec 17. doi: 10.1097/RLU.0000000000002423. [Epub ahead of print]

PMID:
30562198
12.

An examination of the increases in pedestrian motor-vehicle crash fatalities during 2009-2016.

Hu W, Cicchino JB.

J Safety Res. 2018 Dec;67:37-44. doi: 10.1016/j.jsr.2018.09.009. Epub 2018 Sep 27.

PMID:
30553428
13.

In vitro lipid transfer assays of phosphatidylinositol transfer proteins provide insight into the in vivo mechanism of ligand transfer.

Panagabko C, Baptist M, Atkinson J.

Biochim Biophys Acta Biomembr. 2019 Mar 1;1861(3):619-630. doi: 10.1016/j.bbamem.2018.12.003. Epub 2018 Dec 10.

PMID:
30543784
14.

The diagnostic accuracy of 18F-FDG PET/CT in diagnosing fracture-related infections.

Lemans JVC, Hobbelink MGG, IJpma FFA, Plate JDJ, van den Kieboom J, Bosch P, Leenen LPH, Kruyt MC, Glaudemans AWJM, Govaert GAM.

Eur J Nucl Med Mol Imaging. 2018 Dec 7. doi: 10.1007/s00259-018-4218-6. [Epub ahead of print]

PMID:
30523391
15.

Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI.

Reinert CP, Schuhmann MU, Bender B, Gugel I, la Fougère C, Schäfer J, Gatidis S.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):776-787. doi: 10.1007/s00259-018-4227-5. Epub 2018 Dec 8.

PMID:
30535768
16.

Clinical utility of FDG uptake within reticuloendothelial system on F-18 FDG PET/CT for prediction of tumor recurrence in breast cancer.

Bang JI, Yoon HJ, Kim BS.

PLoS One. 2018 Dec 7;13(12):e0208861. doi: 10.1371/journal.pone.0208861. eCollection 2018.

17.

Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer.

Oldan JD, Khandani AH, Fielding JR, Jones EL, Gehrig PA, Sills TM, Roy P, Lin W.

World J Nucl Med. 2018 Oct-Dec;17(4):213-218. doi: 10.4103/wjnm.WJNM_56_17.

18.

Test-retest reliability and convergent validity of (R)-[11C]PK11195 outcome measures without arterial input function.

Plavén-Sigray P, Matheson GJ, Cselényi Z, Jucaite A, Farde L, Cervenka S.

EJNMMI Res. 2018 Nov 29;8(1):102. doi: 10.1186/s13550-018-0455-8.

19.

How to harmonize SUVs obtained by hybrid PET/CT scanners with and without point spread function correction.

Ferretti A, Chondrogiannis S, Rampin L, Bellan E, Marzola MC, Grassetto G, Gusella S, Maffione AM, Gava M, Rubello D.

Phys Med Biol. 2018 Nov 26;63(23):235010. doi: 10.1088/1361-6560/aaee27.

PMID:
30474620
20.

Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphoma: is it significantly affected by contrast-enhanced computed tomography attenuation correction?

Voltin CA, Mettler J, Boellaard R, Kuhnert G, Dietlein M, Borchmann P, Drzezga A, Kobe C.

Nucl Med Commun. 2019 Mar;40(3):249-257. doi: 10.1097/MNM.0000000000000956.

PMID:
30461699

Supplemental Content

Loading ...
Support Center